Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Liabilities and Shareholders Equity (2011 - 2025)

Pluri (PLUR) posted quarterly Liabilities and Shareholders Equity of $30.6 million for Q4 2025, down 0.86% year-over-year from $30.9 million in Q4 2024, and down 9.14% quarter-over-quarter from $33.7 million in Q3 2025.

Pluri (PLUR) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends

Pluri (PLUR) has reported Liabilities and Shareholders Equity for 15 consecutive years, with $30.6 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity fell 0.86% year-over-year to $30.6 million; the TTM figure through Dec 2025 stood at $140.4 million (down 1.31% YoY), while the FY2025 annual figure was $38.7 million, down 2.14% from the prior year.
  • Liabilities and Shareholders Equity eased to $30.6 million in Q4 2025 per PLUR's latest filing, from $33.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $93.5 million in Q2 2021 and bottomed at $30.6 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $54.0 million across 5 years, with a median of $47.7 million in 2023.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 243.94% — and 2024, when it plunged 35.3%.
  • Pluri's Liabilities and Shareholders Equity stood at $81.2 million in 2021, then slipped by 26.18% to $59.9 million in 2022, then sank by 30.64% to $41.6 million in 2023, then dropped by 25.75% to $30.9 million in 2024, then decreased by 0.86% to $30.6 million in 2025.
  • Business Quant data shows PLUR's Liabilities and Shareholders Equity at $30.6 million in Q4 2025, $33.7 million in Q3 2025, and $38.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 30.60 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 30.60 Mn
Sep 30, 2025 33.67 Mn
Jun 30, 2025 38.68 Mn
Mar 31, 2025 37.41 Mn
Dec 31, 2024 30.86 Mn
Sep 30, 2024 35.44 Mn
Jun 30, 2024 39.53 Mn
Mar 31, 2024 36.39 Mn
Dec 31, 2023 41.56 Mn
Sep 30, 2023 44.54 Mn
Jun 30, 2023 50.80 Mn
Mar 31, 2023 56.24 Mn
Dec 31, 2022 59.93 Mn
Sep 30, 2022 59.75 Mn
Jun 30, 2022 68.07 Mn
Mar 31, 2022 79.13 Mn
Dec 31, 2021 81.18 Mn
Sep 30, 2021 83.75 Mn
Jun 30, 2021 93.54 Mn
Mar 31, 2021 79.17 Mn